Oncology/Hematology
Lymphoma
More in Lymphoma
Radiation exposure, type and cumulative dose of chemotherapy drive melanoma risk
Incidence of cytokine release syndrome was minimal with the investigational therapy
Phase III data show promising efficacy with manageable toxicity and feasible delivery
Treatment tied to higher recovery odds and faster time to kidney recovery
FDA boxed warning led to multiple studies on the issue in 2024
News, features, and commentary about cancer-related issues
Studies show promising EFS, PFS, and OS at 3 to 8 years
Novel CD19xCD3 T-cell engager showed high response rate in phase I study
News, features, and commentary about cancer-related issues
Promising single-agent efficacy with manageable safety may reshape initial treatment
Experts talk about long-term data and the importance of infection prophylaxis
Alarming mental health challenges among young cancer survivors, especially males, demand action
Benefit seen in all prespecified subgroups, including high-risk patients
New standard of care for patients in first remission?
